Evommune is a clinical-stage biotechnology company developing novel therapies for immune-mediated chronic inflammatory diseases, aiming to address root causes rather than just symptoms, with a focus on long-term disease progression and complications.
Evommune Highlights:
Overview
- Website: evommune.com
- Headquarters: Palo Alto, California
- Employees: 49
- Founded: 2020
- Email: admin@evommune.com
- Funding: $153.0M
- Revenue: $3.8M
- Valuation: n/a
Contacts
- Email: ***@evommune.com
Similar companies
Frequently Asked Questions related to Evommune
Evommune is located in Palo Alto, California.
Yes, Evommune is a Silicon Valley company.
Evommune total funding is 153.0M.
Evommune revenue is 3.8M.
Evommune’s number of employees is 49.
Evommune’s CEO name is Kyle Carver.
Evommune was founded in 2020.
Evommune’s contact email is admin@evommune.com.
